Characterization of the human endogenous retrovirus K Gag protein: Identification of protease cleavage sites

Retrovirology

Volumn 8, Issue , 2011, Pages

  Kraus, Benjamin ^a   Boller, Klaus ^a   Reuter, Andreas ^a   Schnierle, Barbara S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; PROTEINASE; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; FAMILIA; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; POXVIRUS; PROTEASE CLEAVAGE SITE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; RETROVIRUS; STRUCTURAL GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRUS ASSEMBLY; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RECOMBINANT; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CELL STRAIN 3T3; CHEMISTRY; GENETIC RECOMBINATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; VACCINIA VIRUS; VIRION;

HUMAN ENDOGENOUS RETROVIRUS K; POXVIRIDAE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; ENDOGENOUS RETROVIRUSES; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, GAG; GENES, GAG; GENOME, VIRAL; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; RECOMBINATION, GENETIC; VACCINIA VIRUS; VIRAL PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 79953109068     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-21     Document Type: Article

References (26)

1. Lee YN, Bieniasz PD. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 2007, 3:e10. 10.1371/journal.ppat.0030010, 1781480, 17257061.
2. Bannert N, Kurth R. The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 2006, 7:149-173. 10.1146/annurev.genom.7.080505.115700, 16722807.
3. Magin C, Lower R, Lower J. cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol 1999, 73:9496-9507. 112984, 10516058.
4. Lower R, Lower J, Frank H, Harzmann R, Kurth R. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol 1984, 65(Pt 5):887-898. 10.1099/0022-1317-65-5-887, 6202829.
5. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 2005, 65:4172-4180. 10.1158/0008-5472.CAN-04-2983, 15899808.
6. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF, Johanning GL. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 2007, 120:81-90. 10.1002/ijc.22256, 17013901.
7. Herbst H, Kuhler-Obbarius C, Lauke H, Sauter M, Mueller-Lantzsch N, Harms D, Loning T. Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch 1999, 434:11-15. 10.1007/s004280050298, 10071229.
8. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, Heidmann T. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res 2006, 16:1548-1556. 10.1101/gr.5565706, 1665638, 17077319.
9. Bieda K, Hoffmann A, Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J Gen Virol 2001, 82:591-596.
10. Mueller-Lantzsch N, Sauter M, Weiskircher A, Kramer K, Best B, Buck M, Grasser F. Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease. AIDS Res Hum Retroviruses 1993, 9:343-350. 10.1089/aid.1993.9.343, 8512750.
11. Staib C, Drexler I, Sutter G. Construction and isolation of recombinant MVA. Methods Mol Biol 2004, 269:77-100.
12. Lee SK, Nagashima K, Hu WS. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication. J Virol 2005, 79:4159-4169. 10.1128/JVI.79.7.4159-4169.2005, 1061564, 15767417.
13. Schommer S, Sauter M, Krausslich HG, Best B, Mueller-Lantzsch N. Characterization of the human endogenous retrovirus K proteinase. J Gen Virol 1996, 77(Pt 2):375-379. 10.1099/0022-1317-77-2-375, 8627242.
14. Gottwein E, Krausslich HG. Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J Virol 2005, 79:9134-9144. 10.1128/JVI.79.14.9134-9144.2005, 1168789, 15994808.
15. Karacostas V, Nagashima K, Gonda MA, Moss B. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc Natl Acad Sci USA 1989, 86:8964-8967. 10.1073/pnas.86.22.8964, 298411, 2479031.
16. Konetschny C, Holzer GW, Urban C, Hammerle T, Mayrhofer J, Falkner FG. Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus. J Virol 2003, 77:7017-7025. 10.1128/JVI.77.12.7017-7025.2003, 156191, 12768020.
17. McQuade TJ, Tomasselli AG, Liu L, Karacostas V, Moss B, Sawyer TK, Heinrikson RL, Tarpley WG. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science 1990, 247:454-456. 10.1126/science.2405486, 2405486.
18. Tonjes RR, Boller K, Limbach C, Lugert R, Kurth R. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology 1997, 233:280-291. 10.1006/viro.1997.8614, 9217052.
19. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996, 93:5177-5184. 10.1073/pnas.93.11.5177, 39218, 8643549.
20. Vogt VM. Proteolytic processing and particle maturation. Curr Top Microbiol Immunol 1996, 14:95-131.
21. Martin-Serrano J. The role of ubiquitin in retroviral egress. Traffic 2007, 8:1297-1303. 10.1111/j.1600-0854.2007.00609.x, 17645437.
22. Enserink M. Chronic fatigue syndrome. New XMRV paper looks good, skeptics admit--yet doubts linger. Science 2010, 329:1000. 10.1126/science.329.5995.1000, 20798285.
23. Schnierle BS, Moritz D, Jeschke M, Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther 1996, 3:334-42.
24. Staib C, Lowel M, Erfle V, Sutter G. Improved host range selection for recombinant modified vaccinia virus Ankara. Biotechniques 2003, 34:694-6.
25. Gelderblom HR, Hausmann EH, Ozel M, Pauli G, Koch MA. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 1987, 156:171-176. 10.1016/0042-6822(87)90449-1, 3643678.
26. Albrecht M, Alessandri S, Conti A, Reuter A, Lauer I, Vieths S, Reese G. High level expression, purification and physico- and immunochemical characterisation of recombinant Pen a 1: a major allergen of shrimp. Mol Nutr Food Res 2008, 52(Suppl 2):S186-S195.